Ignite Creation Date:
2025-12-24 @ 11:56 PM
Ignite Modification Date:
2026-01-10 @ 2:08 PM
Study NCT ID:
NCT01963351
Status:
COMPLETED
Last Update Posted:
2014-12-08
First Post:
2013-09-19
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Bevacizumab in Combination With Chemotherapy in Patients With Advanced or Recurrent Non-squamous NSCLC
Sponsor:
University of Athens
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
ML27816
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None